We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Travere Therapeutics
TVTX
$5.78B
| $10.1M | ﹤0.01% |
409,488
-27,469
| -6% | -$710K |
|
1452
Littelfuse
LFUS
$11.6B
| $10.1M | ﹤0.01% |
50,609
-1,378
| -3% | -$329K |
|
1453
ePlus
PLUS
$2.34B
| $10M | ﹤0.01% |
241,874
-71,606
| -23% | -$3.5M |
|
1454
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $10M | ﹤0.01% |
363,778
+12,388
| +4% | +$338K |
|
|
TELL
1455
DELISTED
Tellurian Inc.
TELL
| $9.99M | ﹤0.01% |
4,181,519
-2,572,585
| -38% | -$9.28M |
|
1456
Deluxe
DLX
$1.15B
| $9.99M | ﹤0.01% |
599,888
-20,451
| -3% | -$430K |
|
1457
Cavco Industries
CVCO
$4.55B
| $9.94M | ﹤0.01% |
48,306
+1,169
| +2% | +$277K |
|
1458
Clarivate
CLVT
$1.16B
| $9.93M | ﹤0.01% |
1,057,522
-214,342
| -17% | -$2.71M |
|
1459
MarineMax
HZO
$788M
| $9.91M | ﹤0.01% |
332,665
+40,946
| +14% | +$1.53M |
|
|
JBTM
1460
JBT Marel
JBTM
$6.39B
| $9.87M | ﹤0.01% |
114,713
+6,374
| +6% | +$676K |
|
|
CVET
1461
DELISTED
Covetrus, Inc. Common Stock
CVET
| $9.83M | ﹤0.01% |
470,968
-13,724
| -3% | -$286K |
|
1462
Cactus
WHD
$5.44B
| $9.83M | ﹤0.01% |
255,795
+20,789
| +9% | +$833K |
|
|
MRTX
1463
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.8M | ﹤0.01% |
140,397
-3,447
| -2% | -$255K |
|
|
SIX
1464
DELISTED
Six Flags Entertainment Corp.
SIX
| $9.8M | ﹤0.01% |
553,900
-179,838
| -25% | -$4.06M |
|
1465
argenx
ARGX
$54.1B
| $9.8M | ﹤0.01% |
27,750
+23,322
| +527% | +$8.64M |
|
1466
Flowers Foods
FLO
$1.57B
| $9.79M | ﹤0.01% |
396,316
+23,508
| +6% | +$635K |
|
1467
Bankunited
BKU
$3.36B
| $9.78M | ﹤0.01% |
286,109
-164,853
| -37% | -$6.17M |
|
1468
XPEL
XPEL
$1.38B
| $9.77M | ﹤0.01% |
151,547
+88,412
| +140% | +$5.74M |
|
1469
Ardagh Metal Packaging
AMBP
$3.01B
| $9.76M | ﹤0.01% |
2,016,797
+1,612,654
| +399% | +$9.83M |
|
1470
Mueller Water Products
MWA
$4.16B
| $9.75M | ﹤0.01% |
948,857
-16,341
| -2% | -$190K |
|
|
DENN
1471
DELISTED
Denny's
DENN
| $9.74M | ﹤0.01% |
1,035,426
+580,185
| +127% | +$5.57M |
|
1472
MGIC Investment
MTG
$6.25B
| $9.68M | ﹤0.01% |
755,390
-31,986
| -4% | -$448K |
|
|
NGM
1473
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $9.66M | ﹤0.01% |
738,810
+203,372
| +38% | +$3.08M |
|
1474
Oshkosh
OSK
$9.59B
| $9.66M | ﹤0.01% |
137,472
-3,711
| -3% | -$302K |
|
1475
Digi International
DGII
$3.1B
| $9.63M | ﹤0.01% |
278,521
-67,404
| -19% | -$2.09M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.